Photons, Protons, SBRT, Brachytherapy—What Is Leading the Charge for the Management of Prostate Cancer? A Perspective From the GU Editorial Team
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
SEARCH · Engineering Papers
Results for “Cancer”
Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Phase 3 Multi-Center, Prospective, Randomized Trial Comparing Single-Dose 24 Gy Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer
This prospective phase 3 randomized trial was designed to test whether ultra high single-dose radiation therapy (24 Gy SDRT) improves local control of oligometastatic lesions compared to a standard hypofractionated stereotactic body radiation therapy regimen (3 × 9 Gy SBRT). The secondary endpoint was to assess the associated toxicity and the impact of ablation on clinical patterns of metastatic progression.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
A Tailored Radiation Therapy Strategy for Older Patients With Localized Bladder Cancer Not Eligible for Curative Treatment
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Cosmetic Outcomes of a Phase 1 Dose Escalation Study of 5-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer
Our purpose was to evaluate cosmetic changes after 5-fraction adjuvant stereotactic partial breast irradiation (S-PBI).
62 RADIOLOGY AND NUCLEAR MEDICINE↗
“Standard” Fractionation for Breast Cancer is No Longer Standard
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Underascertainment of Clinically Meaningful Symptoms During Prostate Cancer Radiation Therapy—Does This Vary by Patient Characteristics?
It is well known that physicians underascertain chemotherapy-related toxicity compared with patient self-report. However, symptom underascertainment in radiation therapy and characterization of patient groups at increased risk for underascertainment have not been examined.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Regional Lymph Nodes Radiation and Breast Cancer Related Lymphedema: Where We Stand
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Patient-Reported Quality of Life During Prostate Cancer Radiation Therapy: Insights Into the Patient Experience
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
A Multi-Institutional Analysis of Adjuvant Chemotherapy and Radiation Sequence in Women With Stage IIIC Endometrial Cancer
Our purpose was to evaluate the effect of sequence and type of adjuvant therapy for patients with stage IIIC endometrial carcinoma (EC) on outcomes.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Management Strategy of High-Risk Localized Prostate Cancer: Is there a Transatlantic Consensus?
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
The Evolving Personalized Landscape of Colorectal Cancer Therapies
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Quality of Life After Prostate Cancer Treatment
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Treating Localized High-Risk Prostate Cancer: Do All Roads Lead to Rome?
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Protons Versus Photons for Prostate Cancer: An Answer That Is Long Overdue and Coming
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Comparison of Daily Online Plan Adaptation Strategies for a Cohort of Pancreatic Cancer Patients Treated with SBRT
To study the trade-offs of three online strategies to adapt treatment plans of patients with locally advanced pancreatic carcinoma (LAPC) treated using the CyberKnife with tumor tracking.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
FDA Approves Ga 68 PSMA-11 for Prostate Cancer Imaging
No abstract prepared.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) – A Trans-Tasman Radiation Oncology Group Study
The excellent prognosis of patients with low-risk human papillomavirus (HPV)- associated oropharyngeal squamous cell carcinoma has led to concerns about overtreatment and excessive toxicity with radiation therapy and cisplatin, leading to interest in de-intensification trials. We investigated whether cetuximab, an epidermal growth factor receptor targeting antibody, when combined with radiation therapy would result in a decrease in symptom burden and toxicity with similar efficacy compared with weekly cisplatin.
62 RADIOLOGY AND NUCLEAR MEDICINE↗
Salivary and Dental Complications in Childhood Cancer Survivors Treated With Radiation Therapy to the Head and Neck: A Pediatric Normal Tissue Effects in the Clinic (PENTEC) Comprehensive Review
Radiation therapy (RT) to the head and neck (H&N) region is critical in the management of various pediatric malignancies; however, it may result in late toxicity. This comprehensive review from the Pediatric Normal Tissue Effects in the Clinic (PENTEC) initiative focused on salivary dysfunction and dental abnormalities in survivors who received RT to the H&N region as children.
62 RADIOLOGY AND NUCLEAR MEDICINE↗